CN101265171B - 阿托伐醌的合成工艺 - Google Patents
阿托伐醌的合成工艺 Download PDFInfo
- Publication number
- CN101265171B CN101265171B CN2008100696135A CN200810069613A CN101265171B CN 101265171 B CN101265171 B CN 101265171B CN 2008100696135 A CN2008100696135 A CN 2008100696135A CN 200810069613 A CN200810069613 A CN 200810069613A CN 101265171 B CN101265171 B CN 101265171B
- Authority
- CN
- China
- Prior art keywords
- atovaquone
- ammonium persulfate
- reaction
- naphthoquinones
- acetonitrile
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- KUCQYCKVKVOKAY-CTYIDZIISA-N atovaquone Chemical compound C1([C@H]2CC[C@@H](CC2)C2=C(C(C3=CC=CC=C3C2=O)=O)O)=CC=C(Cl)C=C1 KUCQYCKVKVOKAY-CTYIDZIISA-N 0.000 title claims abstract description 25
- 229960003159 atovaquone Drugs 0.000 title claims abstract description 22
- 238000000034 method Methods 0.000 title claims description 15
- 230000002194 synthesizing effect Effects 0.000 title abstract 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims abstract description 33
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims abstract description 18
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 16
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 16
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229910001870 ammonium persulfate Inorganic materials 0.000 claims abstract description 12
- 238000006243 chemical reaction Methods 0.000 claims abstract description 12
- 229910001961 silver nitrate Inorganic materials 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 238000010992 reflux Methods 0.000 claims abstract description 6
- 239000013078 crystal Substances 0.000 claims abstract description 5
- 238000001816 cooling Methods 0.000 claims abstract description 3
- 238000002425 crystallisation Methods 0.000 claims abstract description 3
- 239000007864 aqueous solution Substances 0.000 claims description 10
- 229960001701 chloroform Drugs 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Substances OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 7
- FRASJONUBLZVQX-UHFFFAOYSA-N 1,4-naphthoquinone Chemical class C1=CC=C2C(=O)C=CC(=O)C2=C1 FRASJONUBLZVQX-UHFFFAOYSA-N 0.000 claims description 4
- 238000001953 recrystallisation Methods 0.000 claims description 4
- 230000008030 elimination Effects 0.000 claims description 3
- 238000003379 elimination reaction Methods 0.000 claims description 3
- 239000004160 Ammonium persulphate Substances 0.000 claims description 2
- 235000019395 ammonium persulphate Nutrition 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 4
- 239000000243 solution Substances 0.000 abstract description 2
- 239000002904 solvent Substances 0.000 abstract description 2
- XRYOPZBKBPUTKS-UHFFFAOYSA-N 2-ethoxynaphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(OCC)=CC(=O)C2=C1 XRYOPZBKBPUTKS-UHFFFAOYSA-N 0.000 abstract 2
- 239000011259 mixed solution Substances 0.000 abstract 2
- 239000003054 catalyst Substances 0.000 abstract 1
- 230000008025 crystallization Effects 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 238000005580 one pot reaction Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 239000000047 product Substances 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 3
- 235000017471 coenzyme Q10 Nutrition 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- 230000006837 decompression Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 3
- 229940035936 ubiquinone Drugs 0.000 description 3
- 238000009835 boiling Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000007039 two-step reaction Methods 0.000 description 2
- CCTJHVLTAJTPBV-UHFFFAOYSA-N 2-chloro-1,4-naphthoquinone Chemical class C1=CC=C2C(=O)C(Cl)=CC(=O)C2=C1 CCTJHVLTAJTPBV-UHFFFAOYSA-N 0.000 description 1
- 102100025287 Cytochrome b Human genes 0.000 description 1
- 108010075028 Cytochromes b Proteins 0.000 description 1
- 229930192627 Naphthoquinone Natural products 0.000 description 1
- 241000224016 Plasmodium Species 0.000 description 1
- 230000003570 biosynthesizing effect Effects 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- UFIVEPVSAGBUSI-UHFFFAOYSA-N dihydroorotic acid Chemical compound OC(=O)C1CC(=O)NC(=O)N1 UFIVEPVSAGBUSI-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000005787 mitochondrial ATP synthesis coupled electron transport Effects 0.000 description 1
- 150000002791 naphthoquinones Chemical class 0.000 description 1
- 239000002423 protozoacide Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100696135A CN101265171B (zh) | 2008-04-30 | 2008-04-30 | 阿托伐醌的合成工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100696135A CN101265171B (zh) | 2008-04-30 | 2008-04-30 | 阿托伐醌的合成工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101265171A CN101265171A (zh) | 2008-09-17 |
CN101265171B true CN101265171B (zh) | 2010-06-02 |
Family
ID=39987891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100696135A Active CN101265171B (zh) | 2008-04-30 | 2008-04-30 | 阿托伐醌的合成工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101265171B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101774901B (zh) * | 2009-01-09 | 2012-10-03 | 武汉泰祥通生物技术有限公司 | 一种制备阿托伐醌的方法 |
CN111099981A (zh) * | 2019-12-31 | 2020-05-05 | 日照巴洛特药业有限公司 | 一种基于阿托伐醌的衍生物的合成方法 |
-
2008
- 2008-04-30 CN CN2008100696135A patent/CN101265171B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN101265171A (zh) | 2008-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105218464B (zh) | 阿昔莫司的合成工艺 | |
CN101891649A (zh) | 一种制备3-氰基苯甲酸甲酯的新生产方法 | |
CN101265171B (zh) | 阿托伐醌的合成工艺 | |
CN102351790B (zh) | 7-溴-6-氯-4(3h)-喹诺酮的合成方法 | |
CN106279083B (zh) | 一种呋喃香豆素类衍生物及其制备方法 | |
CN100560573C (zh) | 一种高纯度来曲唑的制备方法 | |
CN101845070B (zh) | 抗肿瘤药物卡培他滨的合成方法 | |
CN1321972C (zh) | 从苯酐硝化制备3-硝基邻苯二甲酸的反应母液中制备4-硝基邻苯二甲酸的方法 | |
CN104402728A (zh) | 5-氯-2-羟基-3-硝基苯乙酮的制备方法 | |
CN105523985A (zh) | 一种维格列汀的制备方法 | |
CN112645813B (zh) | 一种(r)-3-环己烯甲酸的制备方法 | |
CN102381995B (zh) | 美托洛尔的制备方法 | |
CN104693025A (zh) | 一种制备戊二酸单l-薄荷酯的加料方式 | |
CN110963937B (zh) | 秋水仙碱和别秋水仙碱的不对称合成方法 | |
CN113121354A (zh) | 一种取代联苯化合物的合成方法 | |
CN106749135B (zh) | 取代的苯并呋喃甲酰腙类衍生物及其制备方法 | |
CN101555225B (zh) | 一种多取代喹啉化合物的制备方法 | |
CN102464610B (zh) | 一种美替拉酮的制备方法 | |
CN114369073B (zh) | 一种制备高纯度氢氯噻嗪的方法 | |
CN103483170B (zh) | 一种拆分手性二酮化合物的方法 | |
CN112939855B (zh) | 一种制备含有薁环结构的1,4-二氢吡啶衍生物的方法 | |
CN109641841A (zh) | 一种羟尼酮的制备方法 | |
CN102050775A (zh) | 阿那曲唑杂质α,α,α′,α′-四甲基-5-(丁二酰亚胺-1-基甲基)-1,3-苯二乙腈及其制备方法 | |
CN108358851B (zh) | 2,4-二氯-6-苯乙烯基嘧啶类化合物的纯化方法 | |
CN106349246B (zh) | 奥普力农及9-氮杂吲哚-5-硼酸的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 401121, Chongqing City, the northern New District avenue of stars on the ground floor, No. 60 Venus technology center, building 17 Patentee after: Chongqing Hallochem Pharma Co.,Ltd. Address before: 401121, Chongqing City, the northern New District avenue of stars on the ground floor, No. 60 Venus technology center, building 17 Patentee before: Chongqing Hallochem Pharma Co., Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Technique for synthesizing atovaquone Effective date of registration: 20130117 Granted publication date: 20100602 Pledgee: Changshou District of Chongqing Hongchang credit Company limited by guarantee Pledgor: Chongqing Hallochem Pharma Co.,Ltd. Registration number: 2013500000001 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PM01 | Change of the registration of the contract for pledge of patent right |
Change date: 20170328 Registration number: 2013500000001 Pledgee after: Chongqing Hongchang financing Company limited by guarantee Pledgee before: Changshou District of Chongqing Hongchang credit Company limited by guarantee |
|
PM01 | Change of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20170412 Granted publication date: 20100602 Pledgee: Chongqing Hongchang financing Company limited by guarantee Pledgor: Chongqing Hallochem Pharma Co.,Ltd. Registration number: 2013500000001 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170526 Address after: 401221 Changshou District, Chongqing city in the middle of the road No. 7 Patentee after: Chongqing Kangpu Formosan Union Chemical Corporation Address before: 401121, Chongqing City, the northern New District avenue of stars on the ground floor, No. 60 Venus technology center, building 17 Patentee before: Chongqing Hallochem Pharma Co.,Ltd. |